Stay updated on Pembrolizumab for ALL MRD Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.

Latest updates to the Pembrolizumab for ALL MRD Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a maintenance/version bump with no visible changes to study details.SummaryDifference0.1%

- Check14 days agoChange DetectedUpdated site revision from v3.4.2 to v3.4.3; the previous revision tag has been removed.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedAdded Revision: v3.4.2 and removed older maintenance notices (v3.4.1) on the page, which are site-wide versioning updates rather than changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check50 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the site revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check57 days agoChange DetectedAdded a Show glossary option and updated footer metadata to include Last Update Submitted that Met QC Criteria and Revision: v3.4.0, while removing the older labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check71 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page; this appears to be a backend/content-management update with no changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for ALL MRD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.